Holen Sie sich die Stockscreener-App
1.38
2.13%
-0.03
Handel nachbörslich:
1.38
Schlusskurs vom Vortag:
$1.41
Offen:
$1.4
24-Stunden-Volumen:
428.67K
Relative Volume:
1.88
Marktkapitalisierung:
$123.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-1.5165
EPS:
-0.91
Netto-Cashflow:
$-31.63M
1W Leistung:
+22.12%
1M Leistung:
+65.27%
6M Leistung:
+61.44%
1J Leistung:
-30.65%
1-Tages-Spanne:
$1.35
$1.46
1-Wochen-Bereich:
$1.14
$1.55
52-Wochen-Spanne:
$0.49
$2.5899
Context Therapeutics Inc Stock (CNTX) Company Profile
Firmenname
Context Therapeutics Inc
Sektor
Branche
Telefon
267-225-7416
Adresse
2001 MARKET STREET, PHILADELPHIA
Vergleichen Sie CNTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
1.38 | 126.48M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-04-21 | Eingeleitet | William Blair | Outperform |
| 2025-01-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-11-25 | Eingeleitet | D. Boral Capital | Buy |
| 2024-05-16 | Eingeleitet | Piper Sandler | Overweight |
Context Therapeutics Inc Aktie (CNTX) Neueste Nachrichten
Momentum divergence signals in Context Therapeutics Inc. chartGap Down & Stepwise Trade Signal Implementation - newser.com
Is Context Therapeutics Inc. stock positioned well for digital economyWeekly Market Outlook & Accurate Intraday Trade Tips - newser.com
Is Context Therapeutics Inc. stock in correction or buying zone2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
How to use Fibonacci retracement on Context Therapeutics Inc.2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com
Can a trend reversal in Context Therapeutics Inc. lead to recoveryEarnings Recap Report & Fast Moving Stock Watchlists - newser.com
Context Therapeutics to Present New Data on Two Bispecific T Cell Engagers at SITC 2025 - MyChesCo
Context Therapeutics to Showcase CT-95 Data at AACR 2025 - MSN
What drives Context Therapeutics Inc stock priceCandlestick Trading Patterns & Unlock Patterns Humans Can’t See - earlytimes.in
Is Context Therapeutics Inc. stock ready for a breakoutNew Guidance & Low Risk Entry Point Tips - newser.com
Will Context Therapeutics Inc. continue its uptrendLayoff News & AI Based Buy and Sell Signals - newser.com
Historical volatility pattern of Context Therapeutics Inc. visualizedQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com
Real time social sentiment graph for Context Therapeutics Inc.Portfolio Update Summary & Free Weekly Watchlist of Top Performers - newser.com
Live market analysis of Context Therapeutics Inc.July 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
Context Therapeutics Inc. stock momentum explained2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Context Therapeutics (NASDAQ:CNTX) - MarketBeat
How Context Therapeutics Inc. stock trades before earningsQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com
Is a relief rally coming for Context Therapeutics Inc. holdersIndex Update & AI Driven Stock Reports - newser.com
Is Context Therapeutics Inc. showing signs of accumulationEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Institutions profited after Context Therapeutics Inc.'s (NASDAQ:CNTX) market cap rose US$14m last week but private equity firms profited the most - Yahoo Finance
Context Therapeutics Inc. (NASDAQ:CNTX) Receives $5.20 Consensus PT from Analysts - Defense World
Context Therapeutics Grants Stock Options to New Hire - MSN
Will Context Therapeutics Inc. see short term momentumJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com
Context Therapeutics Announces Poster Presentations at the - GlobeNewswire
Context Therapeutics Inc. to Present Trial Progress and Preclinical Data at SITC 2025 Annual Meeting - Quiver Quantitative
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of ... - Caledonian Record
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting - Stock Titan
Is it too late to sell Context Therapeutics Inc.2025 Winners & Losers & High Win Rate Trade Tips - newser.com
Context Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(4) - MarketScreener
Developing predictive dashboards with Context Therapeutics Inc. dataJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com
Context Therapeutics Inc. (NASDAQ:CNTX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Context Therapeutics announces inducement grant under Nasdaq listing rule - MarketScreener
GlobeNewswire by Notified - The Manila Times
Spyre Therapeutics Announces Grants of Inducement Awards - The Manila Times
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
30,000-Share Option: Context Therapeutics Grants New Hire Award at $0.97 Exercise Price, 10-year Term - Stock Titan
Context Therapeutics Gains 11%, Insider Trades Reap Benefit - simplywall.st
Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Context Therapeutics Inc-Aktie (CNTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Levit Alex C. | Chief Legal Officer, Corp. Sec |
Jun 06 '25 |
Buy |
0.58 |
20,000 |
11,520 |
29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.64 |
40,010 |
25,486 |
80,010 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):